NCT04387513

Brief Summary

Surgical delay in severe endocardits, with neurological complications, is still debated. Early surgery, if indicated, permits to avoid new embolic events, or to fix valvular damages, but can create or increase a cerebral hemorrage. Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in severe left endocarditis, with neurological complications. Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1 year, in patients with severe endocarditis, with neurological complications. Primary endpoint: 1\) Mortality at 1 year Secondary endpoints:

  1. 1.Analyze the factors associated with neurological degradation
  2. 2.Evaluate the neurological tolerance of cardiac surgery.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 18, 2010

Completed
7.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2020

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

17 days

First QC Date

May 10, 2020

Last Update Submit

May 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Death from any cause

    at 1 year after the diagnosis of endocarditis

Secondary Outcomes (1)

  • Neurogical tolerance

    At 6 months

Interventions

Cardiac surgery, if indicated, delayed or not by neurological complications

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients in intensive care unit. They all have an indication of surgery, but they are not all operated (neurological or others contre-indications).

You may qualify if:

  • Left endocarditis
  • With indication of cardiac surgery
  • Severe endocaditis (SOFA score \> or = 3/16)
  • With pre operative neurological complications

You may not qualify if:

  • Age \< 18
  • Right endocarditis without left endocarditis
  • No severe endocarditis (SOFA score \< 3)
  • Ne pre operative neurological complications
  • Endocarditis without indication of cardiac surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Endocarditis

Interventions

Cardiac Surgical Procedures

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDIV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
GROS, Alexandre, Medical Doctor, Intensive Care Unit, Principal Investigator

Study Record Dates

First Submitted

May 10, 2020

First Posted

May 14, 2020

Study Start

August 1, 2010

Primary Completion

August 18, 2010

Study Completion

December 31, 2017

Last Updated

May 19, 2020

Record last verified: 2020-05